reported that TIGIT expression on circulating NK cells (cNK’s) of patients with melanoma did not differ from expression in healthy donors; only to later elaborate that TIGIT expression on tumor infiltrating NK-cells (TiNKs) in those patients is downregulated when compared to TIGIT expression on cNKs from both patients and healthy individuals. This evidence concerns the gene TIGIT and neoplasm.